| 前收市價 | 206.71 |
| 開市 | 206.84 |
| 買盤 | 206.38 x 1200 |
| 賣出價 | 207.15 x 800 |
| 今日波幅 | 206.36 - 208.56 |
| 52 週波幅 | 177.63 - 276.43 |
| 成交量 | |
| 平均成交量 | 274,806 |
| 市值 | 9.736B |
| Beta 值 (5 年，每月) | 1.12 |
| 市盈率 (最近 12 個月) | 27.31 |
| 每股盈利 (最近 12 個月) | 7.57 |
| 業績公佈日 | 2024年5月02日 |
| 遠期股息及收益率 | 1.36 (0.66%) |
| 除息日 | 2024年2月29日 |
| 1 年預測目標價 | 264.50 |
ZacksTeleflex (TFX) Debuts the New Unified UroLift 2 System With ATC
Teleflex's (TFX) new UroLift 2 System with the ATC platform is designed to treat all prostate types.
ZacksHere's Why You Should Retain Teleflex (TFX) Stock for Now
Investors are optimistic about Teleflex (TFX) on robust growth in the Vascular business and strong Urolift prospects.
Insider MonkeyTeleflex Incorporated (NYSE:TFX) Q4 2023 Earnings Call Transcript
Teleflex Incorporated (NYSE:TFX) Q4 2023 Earnings Call Transcript February 22, 2024 Teleflex Incorporated beats earnings expectations. Reported EPS is $3.38, expectations were $3.26. Teleflex Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome […]
